BiomX Inc. Files 8-K with Press Release
Ticker: PHGE · Form: 8-K · Filed: Apr 16, 2026
Sentiment: neutral
Topics: 8-K, disclosure, regulation-fd
TL;DR
BiomX filed an 8-K on 4/16/26, check the press release for updates.
AI Summary
BiomX Inc. filed an 8-K on April 16, 2026, reporting under Regulation FD and other events. The filing includes a press release dated April 16, 2026, and various XBRL documents. The company's mailing and business address is 850 New Burton Road, Suite 201, Dover, DE 19904.
Why It Matters
This 8-K filing indicates BiomX Inc. is making a public disclosure, potentially related to significant company events or updates that could impact investors.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain immediate negative or positive news.
Key Players & Entities
- BiomX Inc. (company) — Filer of the 8-K
- 0001739174 (company) — CIK number for BiomX Inc.
- April 16, 2026 (date) — Filing date and press release date
FAQ
What is the primary purpose of this 8-K filing by BiomX Inc.?
The 8-K filing is for Regulation FD Disclosure and Other Events, and includes a press release dated April 16, 2026.
When was this 8-K filing accepted by the SEC?
The filing was accepted on April 16, 2026, at 17:11:16.
What is BiomX Inc.'s CIK number?
BiomX Inc.'s CIK number is 0001739174.
Where is BiomX Inc. located?
BiomX Inc.'s mailing and business address is 850 New Burton Road, Suite 201, Dover, DE 19904.
What type of business is BiomX Inc. primarily involved in?
BiomX Inc. is primarily involved in Biological Products, (No Diagnostic Substances), classified under SIC code 2836.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2026 regarding BiomX Inc. (PHGE).